The Company also announced it will host an in-person investor day event on Wednesday, February 25, 2026, at the NASDAQ Headquarters in New York City beginning at 8:00am Eastern Time. Guests are ...
NEW YORK--(BUSINESS WIRE)--Spruce Point Capital Management, LLC (“Spruce Point” or “we” or “us”), a New York-based investment management firm that focuses on forensic research and short-selling, today ...
Full-year 2025 revenue guidance was updated to approximately $323 million, reflecting 44% growth compared to 2024. This includes US system revenue of $95 million, driven by greenfield sales and some ...
On Thursday, Spruce Point Capital released a detailed report on PROCEPT BioRobotics (NASDAQ:PRCT), raising concerns about the claims surrounding its market potential and growth prospects, suggesting ...
SAN JOSE, Calif., Feb. 07, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics (Nasdaq: PRCT) (the “Company”), a surgical robotics company focused on advancing patient care by developing transformative ...
Procept BioRobotics Corporation (NASDAQ:PRCT) is one of the best up and coming stocks to buy according to Wall Street. On ...
Morning Overview on MSN
This robotic surgery stock could be a $1M payoff for patient holders
Robotic surgery is shifting from futuristic concept to everyday hospital reality, and the companies behind these systems are ...
With an estimated 40 million men in the U.S. living with benign prostatic hyperplasia, or BPH, Procept Biorobotics has developed a treatment device that certainly holds water. Literally: The AquaBeam ...
PROCEPT BioRobotics Corporation (PRCT) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade primarily reflects an upward trend in earnings ...
We recently compiled a list of the 20 Hidden Gem AI Stocks. In this article, we are going to take a look at where PROCEPT BioRobotics Corporation (NASDAQ:PRCT) stands against the other hidden gem AI ...
The company makes a surgical robotic system for minimally invasive urologic surgery and its shares have dropped by 46% since it raised $164 million in a September IPO. Procept Biorobotics Inc., whose ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results